Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/10/2005CN1213744C Remedies
08/10/2005CN1213743C New use of tea polyphenols for treating prostatosis
08/10/2005CN1213742C Pharmaceutical control of inflammation
08/10/2005CN1213741C New formulation for inhalation having poured bulk density of from 0.28to 0.38g/ml, comprising formoterol
08/10/2005CN1213737C Oral controlled release formulations
08/10/2005CN1213732C Stable pharmaceutical solution formulations for pressurised metered dose inhalers
08/10/2005CN1213730C Treatment method and composition for achieving skin anti-aging benefits by corneum protease activation
08/10/2005CN1213726C Resorcinol compsn.
08/10/2005CN1213724C Local compsn. contg. tocopherol
08/10/2005CN1213659C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and composition containing the same
08/09/2005US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
08/09/2005US6927300 Process for the preparation of Latanoprost
08/09/2005US6927296 Improved preparation of alpha -polymorphic eletriptan hydrobromide, by salt formation in a solution of 2-butanone and water, distillation, dehydration, desolventizing; purity, white color crystals
08/09/2005US6927293 Tyrosine kinase inhibitors
08/09/2005US6927291 Method for the synthesis of 2′,3′-dideoxy-2′,3′-didehydronucleosides
08/09/2005US6927288 Plant thermogenic genes and proteins
08/09/2005US6927239 Methods and compositions for the attenuation and/or prevention of stress/catabolic responses
08/09/2005US6927238 Lipoxin analogs; antiinflammatory activity
08/09/2005US6927236 For therapy of degenerative neuropathy, Alzheimer's disease
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927233 5ht2 agonists for controlling IOP and treating glaucoma
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927231 and stress-related degenerative processes associated with aging or diseases such as cancer, neurodegenerative disease or dysregulation of redox-regulated physiological processes, indicated by prooxidative shift in plasma thiol/disulfide redox state
08/09/2005US6927230 Triazole derivatives
08/09/2005US6927229 Difluorothioacetamides of oxazolidinones as antibacterial agents
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005US6927223 contacting melanoma cell with an effective amount of a serotonin agent selected from fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram, and pharmaceutically acceptable salts thereof
08/09/2005US6927222 Compounds
08/09/2005US6927220 Bicyclic-substituted 4-amino-pyridopyrimidine derivatives
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6927218 Aryl N-cyanoguanidines and methods related thereto
08/09/2005US6927213 For delivering biologically active substances to cells and for transfecting nucleic acids into cells
08/09/2005US6927211 Method for reducing toxicity of combined chemotherapies
08/09/2005US6927210 for controlling an ectoparasite infestation on a small ruminant
08/09/2005US6927209 5-thio-β-D-xylopryanoside derivatives, preparation, method, pharmaceutical compositions containing them and their therapeutic use
08/09/2005US6926914 Proanthocyanidin-containing composition
08/09/2005US6926911 administering a sodium channel blocker to an airway surface in a vehicle comprising potassium sulfate or potassium phosphate as an ionic osmolyte to increase the volume of liquid on the airway surface, for cystic fibrosis
08/09/2005US6926910 Hydrophobe biomolecular structure
08/09/2005US6926909 Chrono delivery formulations and method of use thereof
08/09/2005US6926907 Pharmaceutical compositions for the coordinated delivery of NSAIDs
08/09/2005US6926906 Active pharmaceutical ingredient, especially pseudoephedrine hydrochloride, embedded into an oily matrix; viscosity imparting agents; surfactant; suspending agent; and suspension medium.
08/09/2005US6926905 Liposomak compositions and methods of preparation
08/09/2005US6926903 N-methyl-2-pyrrolidone to impart osteogenesis
08/09/2005US6926178 Valve with a two-component seal
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2303217C Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients
08/09/2005CA2278785C Process for preparing solid pharmaceutical dosage forms
08/09/2005CA2276445C Transdermal hormone-delivering therapeutic system
08/09/2005CA2258892C Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als)
08/09/2005CA2258217C Substituted cyclopentane compounds useful as neuraminidase inhibitors
08/09/2005CA2256687C Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
08/09/2005CA2249330C Method of treating heart failure with endothelin antagonists
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/09/2005CA2189705C Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system
08/09/2005CA2178603C Transdermal therapeutical system for preventing poisoning by organophosphoric neurotoxins that consists of a combination of active substances including a parasympathomimetric and a parasympatholytic agent
08/09/2005CA2139865C Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
08/09/2005CA2136952C Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-– and histamine, serotonin, amines or substances with corresponding receptor activity
08/09/2005CA2095659C Heteroatoms-containing tricyclic compounds
08/06/2005CA2470403A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders
08/06/2005CA2457214A1 Photodynamic therapy for the treatment of acne
08/04/2005WO2005071409A1 Remedy for pancreatic cancer
08/04/2005WO2005071082A1 Antisense oligonucleotide having anticancerous activity
08/04/2005WO2005070971A1 Process for preparing chitosan derivatives, derivatives obtained, compositions comprising them and treatment method
08/04/2005WO2005070970A1 Connective tissue growth factor signaling
08/04/2005WO2005070952A1 Lipid- derivatized bisphosphonic acid
08/04/2005WO2005070949A1 Di-steroidal prodrugs of estradiol
08/04/2005WO2005070946A1 Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound
08/04/2005WO2005070945A1 Novel aminoglycoside antibiotic effective against methicillin resistant staphylococcus aureus (mrsa)
08/04/2005WO2005070941A1 Rifamycin imino derivatives effective against drug-resistant microbes
08/04/2005WO2005070940A2 Rifamycin derivatives effective against drug-resistant microbes
08/04/2005WO2005070938A1 Stable salts of olanzapine
08/04/2005WO2005070936A1 20-esterized camptothecin derivatives, their preparation and the pharmaceutical compositions and the use
08/04/2005WO2005070932A2 Substituted heterocyclic compounds and methods of use
08/04/2005WO2005070930A2 Tetrahydrocarboline compounds as anticancer agents
08/04/2005WO2005070929A1 Vanilloid receptor ligands and their use in treatments
08/04/2005WO2005070922A2 Bis-indole pyrroles useful as antimicrobials agents
08/04/2005WO2005070921A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
08/04/2005WO2005070919A1 N-type calcium channel blockers
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070908A1 Novel long-working beta-2-agonists and use thereof as medicaments
08/04/2005WO2005070906A1 Organic compounds
08/04/2005WO2005070902A1 Therapeutic agents ii
08/04/2005WO2005070901A2 Pyrimidyl phosphonate antiviral compounds and methods of use
08/04/2005WO2005070890A2 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005070884A2 Heterocyclic compounds useful as growth hormone secretagogues
08/04/2005WO2005070883A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005WO2005070874A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005WO2005070868A1 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
08/04/2005WO2005070856A1 Octahydronaphthalene derivative and medicine
08/04/2005WO2005070827A2 Fullerene based amino acids
08/04/2005WO2005070469A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
08/04/2005WO2005070464A2 A tablet formulation of clopidogrel bisulphate
08/04/2005WO2005070463A2 Compositions comprising (s)-amlodipine malate and an angiotensin receptor blocker and methods of their use
08/04/2005WO2005070462A2 Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
1 ... 4588 4589 4590 4591 4592 4593 4594 4595 4596 4597 4598 4599 4600 4601 4602 4603 4604 4605 4606 4607 4608 ... 7860